![Gustav Christensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gustav Christensen
President chez
Phytera, Inc.
Profil
Gustav A. Christensen currently works at Morphic Therapeutic, Inc., as Chairman and Phytera, Inc., as President, Treasurer & Director.
Mr. Christensen also formerly worked at Dyax Corp., as President, Chief Executive Officer & Director from 2011 to 2016, Alpha-Beta Technology, Inc., as Chairman, Morphic Holding, Inc., as Chairman from 2016 to 2024, Apeiron Partners LLC, as Managing Director from 2005 to 2007, Generation Bio Co., as Independent Director from 2017 to 2026, Genetics Institute LLC, as Vice President-Business Development from 1983 to 1988, ImmuLogic Pharmaceutical Corp., as President, BioVentures Investors, as Advisor, Alantos Pharmaceuticals AG, as Member-Management Board, and Baxter International, Inc., as Vice President-Operations Fenwal Laboratories from 1976 to 1983.
Mr. Christensen received his graduate degree from the University of Aarhus and Masters Business Admin degree from Harvard Business School.
Postes actifs de Gustav Christensen
| Sociétés | Poste | Début |
|---|---|---|
Phytera, Inc.
 Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops plant-based and marine-based pharmaceuticals | President | - |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Président | - |
Anciens postes connus de Gustav Christensen
| Sociétés | Poste | Fin |
|---|---|---|
| GENERATION BIO CO. | Directeur/Membre du Conseil | 06/02/2026 |
| MORC HOLD | Président | 16/08/2024 |
| DYAX CORP. | Directeur Général | 22/01/2016 |
BioVentures Investors
 BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors. | Private Equity Investor | 31/03/2009 |
Apeiron Partners LLC
 Apeiron Partners LLC Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01/01/2007 |
Formation de Gustav Christensen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Alpha-Beta Technology, Inc.
 Alpha-Beta Technology, Inc. Electronic ComponentsElectronic Technology Discovers, develops and commercialization of novel carbohydrate-based products | Electronic Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Phytera, Inc.
Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops plant-based and marine-based pharmaceuticals | Commercial Services |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors. | Finance |
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alantos Pharmaceuticals AG
 Alantos Pharmaceuticals AG BiotechnologyHealth Technology Develops and manufactures molecule pharmaceuticals for arthritic and metabolic diseases | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apeiron Partners LLC
Apeiron Partners LLC Investment ManagersFinance Provides investment advice | Finance |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
